Could a High-Fat diet tame Super-Refractory seizures?

NCT ID NCT07496749

First seen Apr 22, 2026 · Last updated Jun 20, 2026 · Updated 10 times

Summary

This study is testing whether a ketogenic diet (a high-fat, low-carbohydrate diet) can help stop super-refractory status epilepticus—a life-threatening condition where seizures continue despite standard medications. The diet is given via feeding tube or by mouth to 84 ICU patients aged 14–80. Researchers will measure how quickly seizures stop using brain wave monitoring.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SUPER-REFRACTORY STATUS EPILEPTICUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Beijing Tongren Hospital, Capital Medical University

    NOT_YET_RECRUITING

    Beijing, 100730, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Chifeng Municipal Hospital

    RECRUITING

    Chifeng, Neimenggu, 024000, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Department of Neurology, Xuanwu Hospital Capital Medical University

    RECRUITING

    Beijing, Beijing Municipality, 100053, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Fujian Medical University Union Hospital

    RECRUITING

    Fuzhou, Fujian, 350001, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Guizhou Provincial People's Hospital

    RECRUITING

    Guiyang, Guizhou, 550002, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Liaocheng People's Hospital

    RECRUITING

    Liaocheng, 252000, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Qilu Hospital,Shandong University

    NOT_YET_RECRUITING

    Jinan, Shandong, 2500012, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • The First Affiliated Hospital of Anhui Medical University

    RECRUITING

    Hefei, Anhui, 230022, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • The First Affiliated Hospital of Guangxi Medical University

    RECRUITING

    Nanning, Guangxi, 530021, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • The First Affiliated Hospital of Harbin Medical University

    RECRUITING

    Harbin, Heilongjiang, 150001, China

    Contact Email: •••••@•••••

  • The First Hospital of Hebei Medical University

    RECRUITING

    Shijiazhuang, Hebei, 050031, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • The First Hospital of Jilin University

    RECRUITING

    Jilin City, 130021, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • The Second Affiliated Hospital of Hainan Medical University

    NOT_YET_RECRUITING

    Haikou, Hainan, 570311, China

    Contact Email: •••••@•••••

  • The Second Affiliated Hospital of Zhejiang University School of Medicine

    RECRUITING

    Hanzhou, Zhejiang, 310009, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

ketogenic diet (a high-fat, low-carbohydrate diet given via feeding tube or by mouth)

What this could lead to

If it works, this could offer a new, drug-free option to stop prolonged seizures in the ICU, potentially reducing brain damage and time on life support.

What could go wrong

This is a relatively small trial (84 people) and the diet can cause side effects like digestive issues or nutrient imbalances. It may not work for everyone, and results may not apply to all patients.

Conditions

The condition(s) this trial relates to.

encephalitis Status Epilepticus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.